Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4086.0
(-0.61%)
JPY 4086.0
(-0.61%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.1 Billion JPY | -8.5% |
| 2022 | 2.29 Billion JPY | -6.71% |
| 2021 | 2.46 Billion JPY | 53.56% |
| 2020 | 1.6 Billion JPY | -9.75% |
| 2019 | 1.77 Billion JPY | -6.08% |
| 2018 | 1.89 Billion JPY | -8.16% |
| 2017 | 2.05 Billion JPY | -6.07% |
| 2016 | 2.19 Billion JPY | -8.9% |
| 2015 | 2.4 Billion JPY | -6.6% |
| 2014 | 2.57 Billion JPY | -7.94% |
| 2013 | 2.79 Billion JPY | -7.78% |
| 2012 | 3.03 Billion JPY | -50.15% |
| 2011 | 6.08 Billion JPY | -36.77% |
| 2010 | 9.62 Billion JPY | -48.84% |
| 2009 | 18.8 Billion JPY | 875.41% |
| 2008 | 1.92 Billion JPY | 2.55% |
| 2007 | 1.88 Billion JPY | -58.45% |
| 2006 | 4.52 Billion JPY | -51.71% |
| 2005 | 9.37 Billion JPY | 212.16% |
| 2004 | 3 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.13 Billion JPY | -46.19% |
| 2024 Q2 | 1.11 Billion JPY | -1.15% |
| 2023 FY | 2.1 Billion JPY | -8.5% |
| 2023 Q1 | 1.2 Billion JPY | -47.63% |
| 2023 Q2 | 1.18 Billion JPY | -1.58% |
| 2023 Q4 | 2.1 Billion JPY | 80.1% |
| 2023 Q3 | 1.16 Billion JPY | -1.44% |
| 2022 Q3 | 1.23 Billion JPY | -1.36% |
| 2022 Q4 | 2.29 Billion JPY | 85.53% |
| 2022 FY | 2.29 Billion JPY | -6.71% |
| 2022 Q1 | 1.27 Billion JPY | -48.25% |
| 2022 Q2 | 1.25 Billion JPY | -1.49% |
| 2021 Q3 | 1.34 Billion JPY | -1.17% |
| 2021 Q2 | 1.36 Billion JPY | -1.37% |
| 2021 Q1 | 1.38 Billion JPY | -13.61% |
| 2021 Q4 | 2.46 Billion JPY | 82.36% |
| 2021 FY | 2.46 Billion JPY | 53.56% |
| 2020 Q3 | 1.49 Billion JPY | -1.78% |
| 2020 FY | 1.6 Billion JPY | -9.75% |
| 2020 Q1 | 1.56 Billion JPY | -12.11% |
| 2020 Q4 | 1.6 Billion JPY | 7.52% |
| 2020 Q2 | 1.51 Billion JPY | -2.76% |
| 2019 Q3 | 1.63 Billion JPY | -3.2% |
| 2019 FY | 1.77 Billion JPY | -6.08% |
| 2019 Q1 | 1.74 Billion JPY | -7.94% |
| 2019 Q4 | 1.77 Billion JPY | 8.7% |
| 2019 Q2 | 1.68 Billion JPY | -3.05% |
| 2018 FY | 1.89 Billion JPY | -8.16% |
| 2018 Q1 | 1.92 Billion JPY | -6.51% |
| 2018 Q4 | 1.89 Billion JPY | 2.83% |
| 2018 Q3 | 1.83 Billion JPY | -2.23% |
| 2018 Q2 | 1.88 Billion JPY | -2.29% |
| 2017 Q3 | 2.01 Billion JPY | -6.99% |
| 2017 Q1 | 2.09 Billion JPY | -4.38% |
| 2017 FY | 2.05 Billion JPY | -6.07% |
| 2017 Q2 | 2.16 Billion JPY | 3.15% |
| 2017 Q4 | 2.05 Billion JPY | 2.39% |
| 2016 Q2 | 2.27 Billion JPY | -0.91% |
| 2016 Q4 | 2.19 Billion JPY | -2.97% |
| 2016 Q3 | 2.25 Billion JPY | -0.83% |
| 2016 Q1 | 2.29 Billion JPY | -4.45% |
| 2016 FY | 2.19 Billion JPY | -8.9% |
| 2015 Q4 | 2.4 Billion JPY | 2.82% |
| 2015 Q1 | 2.49 Billion JPY | -3.15% |
| 2015 Q2 | 2.35 Billion JPY | -5.65% |
| 2015 FY | 2.4 Billion JPY | -6.6% |
| 2015 Q3 | 2.33 Billion JPY | -0.59% |
| 2014 FY | 2.57 Billion JPY | -7.94% |
| 2014 Q1 | 2.5 Billion JPY | -10.33% |
| 2014 Q4 | 2.57 Billion JPY | 5.1% |
| 2014 Q3 | 2.45 Billion JPY | -1.53% |
| 2014 Q2 | 2.48 Billion JPY | -0.8% |
| 2013 Q3 | 2.58 Billion JPY | -2.19% |
| 2013 Q4 | 2.79 Billion JPY | 8.08% |
| 2013 FY | 2.79 Billion JPY | -7.78% |
| 2013 Q1 | 2.64 Billion JPY | -12.96% |
| 2013 Q2 | 2.64 Billion JPY | 0.23% |
| 2012 FY | 3.03 Billion JPY | -50.15% |
| 2012 Q1 | 5.45 Billion JPY | -10.32% |
| 2012 Q3 | 2.77 Billion JPY | -2.11% |
| 2012 Q4 | 3.03 Billion JPY | 9.22% |
| 2012 Q2 | 2.83 Billion JPY | -48.0% |
| 2011 Q1 | 13.57 Billion JPY | 41.12% |
| 2011 Q2 | 8.12 Billion JPY | -40.19% |
| 2011 Q4 | 6.08 Billion JPY | -26.47% |
| 2011 Q3 | 8.27 Billion JPY | 1.87% |
| 2011 FY | 6.08 Billion JPY | -36.77% |
| 2010 Q3 | 11.76 Billion JPY | -1.11% |
| 2010 Q2 | 11.89 Billion JPY | -28.24% |
| 2010 FY | 9.62 Billion JPY | -48.84% |
| 2010 Q1 | 16.57 Billion JPY | -11.86% |
| 2010 Q4 | 9.62 Billion JPY | -18.2% |
| 2009 Q2 | 16.83 Billion JPY | 0.0% |
| 2009 FY | 18.8 Billion JPY | 875.41% |
| 2009 Q4 | 18.8 Billion JPY | -26.8% |
| 2009 Q3 | 25.69 Billion JPY | 52.59% |
| 2009 Q1 | - JPY | 0.0% |
| 2008 FY | 1.92 Billion JPY | 2.55% |
| 2007 FY | 1.88 Billion JPY | -58.45% |
| 2006 FY | 4.52 Billion JPY | -51.71% |
| 2005 FY | 9.37 Billion JPY | 212.16% |
| 2004 FY | 3 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | 87.567% |
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.957% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 99.499% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | 81.928% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -1988.949% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | 26.88% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | 45.455% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 98.984% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -394.118% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -469.106% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | 83.493% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 87.633% |
| Tsumura & Co. | 79.69 Billion JPY | 97.365% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -21.598% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -760.656% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 98.962% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 92.746% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 95.587% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 89.974% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | 44.867% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | 75.915% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -3400.0% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -409.091% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | 77.86% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 97.467% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -130.011% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 93.056% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | 25.671% |